Atipical multiple sclerosis, Marburg variant: a case report and review

E.V. Popova, V.V. Bryukhov, A.N. Boyko, M.V. Krotenkova


This article presents a clinical case of aggressive form of multiple sclerosis — Marburg variant. The review discusses the issues of diagnosis and possible therapies according to international published data.


multiple sclerosis; Marburg variant; fulminant multiple sclerosis


Wattamwar P, Baheti N, Kesavadas C, Nair M, Radhakrishnan A. Evolution and long term outcome in patients presenting with large demyelinating lesions as their first clinical event. Journal of the Neurological Sciences. 2010;297(1-2):29-35. doi:10.1016/j.jns.2010.06.030.

Freedman M, Rush C. Severe, Highly Active, or Aggressive Multiple Sclerosis. Continuum: Lifelong Learning in Neurology. 2016;22(3):761-784. doi:10.1212/con.0000000000000331.

Masdeu J, Quinto C, Olivera C, Tenner M, Leslie D, Visintainer P. Open-ring imaging sign: Highly specific for atypical brain demyelination. Neurology. 2000;54(7):1427-1433. doi:10.1212/wnl.54.7.1427.

Jeffery D, Lefkowitz D, Crittenden J. Treatment of Marburg Variant Multiple Sclerosis with Mitoxantrone. Journal of Neuroimaging. 2004;14(1):58-62. doi:10.1177/1051228403259393.

Oreja-Guevara C, Gómez-Pinedo U, García-López J et al. Inhibition of neurogenesis in a case of Marburg variant multiple sclerosis. Multiple Sclerosis and Related Disorders. 2017;18:71-76. doi:10.1016/j.msard.2017.09.024

Suzuki M, Kawasaki H, Masaki K et al. An Autopsy Case of the Marburg Variant of Multiple Sclerosis (Acute Multiple Sclerosis). Internal Medicine. 2013;52(16):1825-1832. doi:10.2169/internalmedicine.52.0425

Nunes J, Radbruch H, Walz R et al. The most fulminant course of the Marburg variant of multiple sclerosis - autopsy findings. Multiple Sclerosis Journal. 2014;21(4):485-487. doi:10.1177/1352458514537366

Masuda H, Mori M, Katayama K, Kikkawa Y, Kuwabara S. Anti-Aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Balo’s concentric Lesions. Internal Medicine. 2013;52(13):1517-1521. doi:10.2169/internalmedicine.52.9330.

Brown J, Coles A, Jones J. First use of alemtuzumab in Balo’s concentric sclerosis: a case report. Multiple Sclerosis Journal. 2013;19(12):1673-1675. doi:10.1177/1352458513498129.

Nozaki K, Abou-Fayssal N. High dose cyclophosphamide treatment in Marburg variant multiple sclerosis.Journal of the Neurological Sciences. 2010;296(1-2):121-123. doi:10.1016/j.jns.2010.05.022

Grooters G, Visser L, Barkhof F, van der Knaap M, van Asseldonk J. Mystery Case: Balo concentric sclerosis. Neurology. 2013;80(7):e71-e72. doi:10.1212/wnl.0b013e3182824e7d.

Chitnis T, Hollmann T. CADASIL mutation and Balo concentric sclerosis: A link between demyelination and ischemia?. Neurology. 2012;78(3):221-223. doi:10.1212/wnl.0b013e31823fcd3c.

Berghoff M, Schlamann M, Maderwald S et al. 7 Tesla MRI demonstrates vascular pathology in Baló’s concentric sclerosis. Multiple Sclerosis Journal. 2012;19(1):120-122. doi:10.1177/1352458512445302.

Popova E.V., Bryukhov V.V., Boyko A.N., Krotenkova M.V., Konovalova O.E., Sharanova S.N. Atypical multiple sclerosis - Balo’s concentric sclerosis: two case-reports and a review. Zhurnal nevrologii i psikhiatrii im SS Korsakova. 2017;117:2(2):50-53. doi:10.17116/jnevro20171172250-53. In Russian.

Bryukhov V.V., Popova E.V., Krotenkova M.V., Boyko A.N. Radiologically isolated syndrome - MRI criteria and management tactic. Zhurnal nevrologii i psikhiatrii im SS Korsakova. 2016; 116:10(2):47-52. doi:10.17116/jnevro201611610247-52. In Russian

Gobbin F, Marangi A, Orlandi R et al. A case of acute fulminant multiple sclerosis treated with alemtuzumab. Multiple Sclerosis and Related Disorders. 2017;17:9-11. doi:10.1016/j.msard.2017.06.007

Yevtushenko S.K., Moskalenko M.A. Multiple sclerosis in children. Kyev, 2010. 253 p.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2020


   Seo анализ сайта